These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4001847)

  • 1. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis.
    Strandvik B; Samuelson K
    Scand J Gastroenterol; 1985 Apr; 20(3):381-4. PubMed ID: 4001847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis.
    Arborgh B; Eklund A; Norman A; Strandvik B
    Scand J Gastroenterol; 1980; 15(1):73-80. PubMed ID: 7367826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bile acids as markers of juvenile liver disease in alpha 1-antitrypsin deficiency.
    Nemeth A; Samuelson K; Strandvik B
    J Pediatr Gastroenterol Nutr; 1982; 1(4):479-83. PubMed ID: 6985262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fasting serum bile acid concentration in patients with liver and gastrointestinal disorders.
    Samuelson K; Aly A; Johansson C; Norman A
    Scand J Gastroenterol; 1981; 16(2):225-34. PubMed ID: 7313533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.
    Robb TA; Davidson GP; Kirubakaran C
    Gut; 1985 Nov; 26(11):1246-56. PubMed ID: 4065698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease.
    Drzymała-Czyż S; Dziedzic K; Szwengiel A; Krzyżanowska-Jankowska P; Nowak JK; Nowicka A; Aringazina R; Drzymała S; Kashirskaya N; Walkowiak J
    Dig Liver Dis; 2022 Jan; 54(1):111-117. PubMed ID: 34305015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    Colombo C; Crosignani A; Alicandro G; Zhang W; Biffi A; Motta V; Corti F; Setchell KDR
    J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bile acid composition in patients with cystic fibrosis.
    Setchell KD; Smethurst P; Giunta AM; Colombo C
    Clin Chim Acta; 1985 Sep; 151(2):101-10. PubMed ID: 4042374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassay of serum conjugates of cholic acid in cystic fibrosis.
    Davidson GP; Corey M; Morad-Hassel F; Sondheimer JM; Crozier D; Forstner GG
    J Clin Pathol; 1980 Apr; 33(4):390-4. PubMed ID: 6901734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and urinary bile acids in patients with primary biliary cirrhosis.
    Samuelson K; Aly A; Johansson C; Norman A
    Scand J Gastroenterol; 1982 Jan; 17(1):121-8. PubMed ID: 7134826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of serum bile acid levels in biopsy-proved cirrhosis.
    Dasher CA; Hirschowitz BI; Spenney JG; Gibson RG; Mihas AA
    South Med J; 1977 Aug; 70(8):968-9, 973. PubMed ID: 887983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency.
    Colombo C; Roda A; Roda E; Piceni Sereni L; Brega A; Fugazza R; Giunta A
    J Pediatr Gastroenterol Nutr; 1984 Sep; 3(4):556-62. PubMed ID: 6481566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum glycine-conjugated bile acids in pediatric hepatobiliary disorders.
    Lloyd-Still JD; Demers LM
    Am J Clin Pathol; 1979 Apr; 71(4):444-51. PubMed ID: 443203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate 19-9 antigen is not a marker of liver disease in patients with cystic fibrosis.
    Bettinardi N; Felicetta I; Tomasi PA; Colombo C
    Clin Chem Lab Med; 2003 Mar; 41(3):311-6. PubMed ID: 12705340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism.
    Isenberg JN
    Semin Liver Dis; 1982 Nov; 2(4):302-13. PubMed ID: 6763343
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum.
    Angelin B; Björkhem I; Einarsson K; Ewerth S
    J Clin Invest; 1982 Oct; 70(4):724-31. PubMed ID: 7119112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts.
    Roy CC; Weber AM; Morin CL; Lepage G; Brisson G; Yousef I; Lasalle R
    J Pediatr Gastroenterol Nutr; 1982; 1(4):469-78. PubMed ID: 7186061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bile acids in primary biliary cirrhosis.
    Bloomer JR; Allen RM; Klatskin G
    Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.